A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes
Clinical trial NCT06901349 · WITHDRAWN
Trial details
- NCT number
- NCT06901349
- Sponsor
- Eli Lilly and Company
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-23
- Primary completion
- 2025-06-10
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.